Back to VCEL
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
1 competitor in Ischemic Dilated Cardiomyopathy (IDCM)
View Full LandscapeDrug Information
Target Indication
Ischemic Dilated Cardiomyopathy (IDCM)
Clinical Trial
NCT01670981Last updated: 12/29/2025
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Developer
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts